Inocor

Active Ingredient(s): Inamrinone
FDA Approved: * July 31, 1984
Pharm Company: * SANOFI AVENTIS US
Category: Heart (Cardiac)

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".



Inocor Overview

Amrinone, also known as inamrinone, and sold as Inocor, is a pyridine phosphodiesterase 3 inhibitor.[1] It is a drug that may improve the prognosis in patients with congestive heart failure.[2] Amrinone has been shown to increase the contractions initiated in the heart by high gain calcium induced calcium release (CICR).[3] The positive inotropic effect of amrinone is mediated by the selective enhancement of high gain CICR which contributes to ...

Read more Inocor Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Amrinone

Recent Inocor Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Inamrinone
  • Injection: 5mg/ml
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

Other drugs which contain Inamrinone or a similar ingredient: (2 results)




Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 10 August 2020.

We are committed to your privacy.

Copyright © 2005-2020 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA